Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07820917). This is a study registration, not published results. Lead sponsor: University of Michigan. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 100 participants (ESTIMATED). Conditions: Cirrhosis. Interventions: DEVICE: Transcutaneous Electrical Acustimulation (TEA); DEVICE: Sham Transcutaneous Electrical Acustimulation (TEA). Primary outcome measures: Retention , Approximately day -14, day 1, and day 56; Device adherence , Approximately week 8; Questionnaire completion , Approximately week 8; Acceptability of Intervention Measure (AIM) score , Approximately week 8 and week 12. Brief summary: This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression. Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.